230 related articles for article (PubMed ID: 2724610)
1. [A clinical study on CA 15-3, CEA, SCC-Ag in patients with squamous cell carcinoma of the lung].
Moriya H; Suzuki S; Aizumi J; Kimura K; Urabe S; Higuci Y; Hoshi K
Rinsho Hoshasen; 1989 Jan; 34(1):63-6. PubMed ID: 2724610
[TBL] [Abstract][Full Text] [Related]
2. Value of CEA and SCC-Ag in bronchoalveolar lavage (BAL) and serum of patients with lung carcinoma.
Nikliński J; Chyczewska E; Furman M; Kowal E; Kozłowski M
Neoplasma; 1992; 39(5):283-5. PubMed ID: 1331827
[TBL] [Abstract][Full Text] [Related]
3. [Clinical investigation of neuron-specific enolase, squamous cell carcinoma-related antigen and carcinoembryonic antigen in carcinoma of the lung].
Tashiro T; Nagai H; Yamasaki H; Kuroda Y; Goto Y; Goto J; Nasu M
Gan To Kagaku Ryoho; 1986 Jul; 13(7):2383-8. PubMed ID: 3015044
[TBL] [Abstract][Full Text] [Related]
4. [Tumor markers in patients with head-neck carcinomas].
Walther EK; Dahlmann N; Gorgulla HT
Laryngorhinootologie; 1990 May; 69(5):271-4. PubMed ID: 2354022
[TBL] [Abstract][Full Text] [Related]
5. Tumor markers CA 125, squamous cell carcinoma antigen, and carcinoembryonic antigen in patients with adenocarcinoma of the uterine cervix.
Duk JM; Aalders JG; Fleuren GJ; Krans M; De Bruijn HW
Obstet Gynecol; 1989 Apr; 73(4):661-8. PubMed ID: 2648225
[TBL] [Abstract][Full Text] [Related]
6. [The diagnostic value of the tumor markers CEA, "Ca 19-9", "Ca 125", "Ca15-3" and "SCC" for the detection of recurrent tumors in patients with tumors of the head and neck].
Zöller J; Fiehn W; Mende U; Hotz G
Dtsch Z Mund Kiefer Gesichtschir; 1990; 14(4):254-9. PubMed ID: 2134649
[TBL] [Abstract][Full Text] [Related]
7. [Ca 19-9 and Ca 50 in the diagnosis of bronchial carcinoma: comparison with CEA].
Pecchio F; Rapellino M; Oliaro A; Moscato D; Adamo R; Albertino B; Lo Faso C; Faga C; Borasio P
Minerva Med; 1988 Mar; 79(3):183-6. PubMed ID: 2834670
[TBL] [Abstract][Full Text] [Related]
8. [Clinical evaluation of tumor markers in head and neck squamous cell carcinomas].
Yoneda K; Hirota J; Yamamoto T; Ueta E; Osaki T
Gan No Rinsho; 1990 Mar; 36(4):458-64. PubMed ID: 2181163
[TBL] [Abstract][Full Text] [Related]
9. [Clinical evaluation of serum carbohydrate antigen 19-9 in carcinoma of the lung--a comparison with carcinoembryonic antigen].
Hayashibe A; Kodama T; Nishiwaki Y; Kudou H; Inoue Y; Nukariya N; Kaguraoka H; Kuroki M; Takahashi K; Nishiyama Y
Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):711-5. PubMed ID: 3030198
[TBL] [Abstract][Full Text] [Related]
10. [Diagnostic value of pleural effusion carcinoembryonic antigen, squamous cell carcinoma related antigen and neuron-specific-enolase in patients with lung cancer].
Fujii M; Kiura K; Kamei H; Segawa Y
Nihon Kyobu Shikkan Gakkai Zasshi; 1988 May; 26(5):519-23. PubMed ID: 2852270
[No Abstract] [Full Text] [Related]
11. Cytokeratin 19 fragment CYFRA 21-1 compared with carcinoembryonic antigen, squamous cell carcinoma antigen and neuron-specific enolase in lung cancer. Results of an international multicentre study.
Ebert W; Dienemann H; Fateh-Moghadam A; Scheulen M; Konietzko N; Schleich T; Bombardieri E
Eur J Clin Chem Clin Biochem; 1994 Mar; 32(3):189-99. PubMed ID: 7518259
[TBL] [Abstract][Full Text] [Related]
12. Clinical importance of tumour markers in the diagnosis of squamous-cell carcinoma of the esophagus.
Dei Poli M; Albertino B; Gasparri G; Casalegno PA; Oliaro A; Rapellino M; Pecchio F
Panminerva Med; 1990; 32(3):105-7. PubMed ID: 2077475
[TBL] [Abstract][Full Text] [Related]
13. [The measurement of SCC antigen in squamous cell carcinoma of the lung].
Masuoka T; Matueda Y; Ookawa H; Watanabe K; Mimoto S
Gan No Rinsho; 1985 Jul; 31(8):914-8. PubMed ID: 4032769
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of squamous cell carcinoma antigen (SCC-Ag) in the diagnosis and follow-up of patients with non-small cell lung carcinoma.
Nikliński J; Furman M; Laudański J; Kozłowski M
Neoplasma; 1992; 39(5):279-82. PubMed ID: 1331826
[TBL] [Abstract][Full Text] [Related]
15. [Diagnostic value of the assay of carbohydrate antigen 19-9 in patients with primary bronchial cancer].
Letanche G; Ogier I; Weynants P; Hartmann DJ; Ville G; Cordier JF; Brune J
Rev Pneumol Clin; 1985; 41(5):314-6. PubMed ID: 3006207
[TBL] [Abstract][Full Text] [Related]
16. [Clinical significance of serum levels of SCC antigen in patients with esophageal squamous cell carcinoma].
Ikeda K; Terashima M; Ishida K; Okamoto K; Suzuki S; Murakami K; Ohtsu T; Suzuki K; Niitsu Y; Obonai H
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):677-82. PubMed ID: 3355186
[TBL] [Abstract][Full Text] [Related]
17. [Tumor markers. I. Their significance in the preoperative assessment of lung neoplasms].
Ratto GB; Capponi G; De Grandi R; Augeri C; Secco GB; Fardelli R
Minerva Chir; 1990 Oct; 45(20):1265-72. PubMed ID: 1964495
[TBL] [Abstract][Full Text] [Related]
18. [Tumor-associated markers in malignant lung neoplasms].
Piancino G; Racca P; Rayneri W; Piantino P; Cerchier A; Pecchio F
Minerva Med; 1986 Jan; 77(1-2):19-25. PubMed ID: 3945411
[TBL] [Abstract][Full Text] [Related]
19. [Measurement of carcinoembryonic antigen, squamous cell carcinoma related antigen and neuron-specific enolase in the bronchoalveolar lavage fluid in patients with peripheral lung cancer].
Fujii M; Kiura K; Kamei H; Segawa Y
Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Apr; 27(4):452-5. PubMed ID: 2552209
[TBL] [Abstract][Full Text] [Related]
20. [Comparative analysis of serum levels of CA-50, CA-125, CA-19.9, enolase and CEA in bronchopulmonary cancer].
Maréchal F; Deltour G; Incatasciato C; Carpentier Y; Cattan A
Rev Pneumol Clin; 1987; 43(5):224-8. PubMed ID: 2829332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
